µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º m|O7@N
RhG9Xw9
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ %#rH~E
s!q6OVJ-
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) Y9TaU]7]
1)aB']K%
1. ICAM-1
Tsez&R$k
Ojx1IL
2. interleukin 12(IL-12) qbjLTE=
Y5~_y?BX
3. tumor infiltrating lymphocyte "lo:"y(u
{XMF26C#
4. TCR/CD3 complex -d+q +l>0
qV$\.T>x
5. hematopoietin receptor family \:
H&.VQ"
ic:_v?k
6. individual idiotype(IdI) .17WF\1HC.
5-Vdq
7. integrin _2V L%
%aU4d
e^
8. colony-stimulatory factor (CSF) (
w(GJ/g
/wB<1b"
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© )W!8,e+%
'~{^c}
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? gaaW:* *y
9x/HQ(1
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ LlP_`fA
vgSs]g
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠMP\$_;&xB
<N11$t&_
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ % (R10G
wSHE~Xx
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) Ep/4o<N(
p#W[he
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ m5lMh14E
cQ~}qE>I
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) U`_(Lq%5W
n*G[ZW*Uc
3. immunoglobulin superfamily (IgSF) uBI?nv,
>VnkgY
4. selectin %pmowo~{
)=TD}Xb
5. anti-idiotypic antibody (¦ÁId) qepsR/0M
K*Y.mM)
6. major histocompatibility complex(MHC) `T2RaWR4=
8`Fo
^c=j
7. immunotolerance 6>ZUx}vYj
xoI;s}*E
8. biological reponse modifier(BRM) kxt@t#
RWtD81(oC'
9. immune reponse gene (Ir gene) O1IR+"0
I=X-e#HM?
10. reshaped antibody (or reconstituted antibody) #y13(u,dN
MkZm
=Sf
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© :U!kn b"/>
v'0A$`w`
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ &3lg\&"
o
%sBU
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? [mphiH/
=jIB5".
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ ^T`)ltI]V
0FmYM@Wc
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? U
8L%=/N>B
braHWC'VYg
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ VqqI%[!Aw
: xI SS
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? )*@n G$i99
asqbLtQ
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 8enlF\I8g
`%}SK~<R
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ ! iuD
mL
:U_k*9z}=
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? vI3L <[W
9x@( K|
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 6L[ Yn?;
^=:e9i3u
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ("-Co,4ey
B M5+;h !
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ,:POo^!/fT
R:c$f(aKv%
̉񧄤 ("0 7t/||
\6o%gpUkD
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© B1)gudP`
-xs@rV`
1. CD8 0Oy.&C T
-X+G_rY
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) R-8>,
iAD'MB
3. immunoglobulin fold(Ig fold) u#(VR]u\7
M )4-eo
4. cadherin (Ca-dependent cell adhesion moleculers) -]yM<dP
O@.C.5Ep
5. idiotype-anti-idiotypic antibody immune network theory ILi{5L
E4;vC ?K{
6. HLA class II antigen cV]c/*zA
OpFe=1Q
7. complementarity-determining region (CDR) @BQJKPF
*
"#zSk=52z
8. perforin(or pore-forming protein ,PFP) KnL-qc
|v,%!ps
9. high affinity IL-2 receptor {A!1s;
9! 'qLO
10. artificial active immunization SURbH;[
Y9V%eFY5E
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© TCShS}q;%
2gP^+.
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠk;EG28
_:dt8+T#
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 NsbC0
xLd
DX3xWdnr
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ sKE7U>mz|
Eo
h4#fZ\N
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ `)i'1E[9
NT(gXEZ
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ YoC{ t&rY
SNLZU%jan
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? jV W .=FK
5a8[0&hA 2
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ k[_)5@2
KImBQ2 ^Tu
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ n,,hE_
4?eO1=
a
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ tr[(,kX
aL)}S%5o?
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ FCr^D$_w
&-5`Oln
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© G
51l_
jRn5)u
1. immunoglobulin gene rearrangement N*^iOm]Y
<^+x}KV I
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) T
O]wD^`
1\t# *N
3. flow cytometry(FCM) NA :_yA"
2`Dqu"TWh
4. carrier effect {fd/:B 7T
L- '{
5. positive selection of T lymphocytes in thymus &EUI
LMGo8%2I
6. mouse TH1(Th1) and TH2(Th2) subsets SlaHhq3
og?>Q i Tr
7. perforin (pore-forming protein ,PFP) _N @h
x$SxGc~4gb
8. ADCC(antibody-dependent cell-mediated cytotoxicity) 1WP(=7$.
^ ,cwm:B@
9. SH-2(src-homology region 2) uY_vX\;67z
Z[Z3x6
6
10. Ab2¦Â (internal image) 5LX'fL7zU
78MQoG<
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© S-
N
[
u3k{s
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? hI#1Ybl
NZQl#ZJH:
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? [6u8EP0xM
x
&
ZW
f?
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠJ$>9UCk7B
Chs#}=gzi
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ tb1w 6jaU
= }!4%.$
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠX+%5q =N
1w$X;q"
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) n7p,{KSQ
"q]r{0
ÃâÒßѧרҵ£º w|G4c^KH
8h '~*
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ .QLjaEja
-L6V)aK&
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? mzbMX
<
]w5j?h"b
´«È¾²¡Ñ§×¨Òµ£º B.Y8O^rx
}1BpIqee
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ q_b,3Tp
B(ZK\]
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ lBZhg~{
EHlkt,h*
Ïû»¯×¨Òµ£º yk0#byW`
;a9`z+ K
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£
) k6O
egn9O
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? 5-B % 08T
;0JK>c
]#
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ kNC]q,ljt5
{Q/_I@m].
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© P~9y}7Q\0
PlC8&$
1. Fas(CD95)/FasL }~+_|
M|9=B<6`7
2. common chain of cytokine receptor q6AL}9]9
K0-AP
$
3 . TCR/CD3 complex i7|sVz=
3x3 =ke!
4. negaive selection of thymocytes "3e1 7dsY
oeF0t'%
5. artificial active immune 9`|~-b
$e/[!3CASP
6. anti-idiotypic `\M}~
K;P<c,9X/
7. IgSF _2wH4^Vb
yd~}CF
8. Integrin NKRI|'Y,
vfpK|=[7o
9. chemokine x>eV$UJ
3.@I\p}
10. B7/CD28 K/IG6s;Xj
"Wn8}T*
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© ]>H'CM4JR
)Nkf'&
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
i=aK ?^+
~X<Ie9m1x
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ Uk<2XGj
y*7<tj.`b0
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ hVf;{p
&
0;SRmj@W
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ &KPJB"0L
o@W:PmKW
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ AH'4k(-
g#s hd~e
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ ql2O%B.6?
la{Iqm{i
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© G*'1[Bu
9ELRn
@5.
1. B7/CD28 m'YYkq(5%Z
X(dHhO
2. Th1 subset {~{</ g/
t;L7H E@Y
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© =L9;8THY
ObEp0-^?
4. antibody affinity maturation }/g1s71
) ={
H
5. AP-1 (8jQdbZU
1rGi"kdf
6. single chain variable fragment£¨ScFv£© [&K"OQ^\2h
(U^f0wJg
7. NK cell receptor H&h"!+t(#
R~H +.Vh
8. Zinkernagel-Doherty phenomenon -$tf`
&LDA=B
9. Ig fold 'q, L*
9KDm<Q-mf
10. CD40/CD40L 0S$6j-"
`z~L0h
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© 2R>!Wj'G+o
f&88N<)
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ vCsJnKqK
-PLh|
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ >@?`n}r|
s]Qo'q2
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ |rwx;+
#[yZP9
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ NNn sq@?6
}^]TUe@a
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ ;I!Vba
4
'G osQ85
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ WIYWql>*
Twq, 6X-
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ `C>De4nT@
zp:EssO=Q
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© UB3hC`N\
G}#p4\/
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ]Ia}H+ &
( =t41-l
1.Co-stimulators (or co-stimulating molecules) OXD*ZKi8
{q.|UCg[
L
2.NK-kB cNiNLwc
\.Z
/
3.Immunoglobulin superfamily M {Hy=:K+
Bnh*;J0
4.antigen-presenting cell (APC) h4N&Ybfo
^\7GFpc
5.death domain 2|$G<f
CM4#Nn=i~
6.CCR and CXCR g
![?P"i^t
O[15xH,
7.Lectin (or mitogen) &{ZTtK&JF
L^e%oQ>s
8.Clusters of differentiation, CD) UqNUP+K
:aWC6"ik-W
9.B7 family v?s%qb= T
wPl9%
10.Cytotoxic T lymphocyte, CTL) B~47mw&b
Y%Tm
`$^V
11.IL-15 and IL-15 receptor (IL-15R) 8]&\FA 8
Hgbrlh
12.MHC restriction ~qkn1N%'
k FCdGl
13.Affinity-chromatography +k\cmDc
b
T[%@B"
14.Cyctosprin A, CsA t
(Gg
1
>j)y7DSE
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) nTCwLnX(O
/A93mY[
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© lK3{~\J-
M?QX'fia
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ZiC~8p_f
0X4I-xx#
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ u1ahAk7
a]@BS6
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ _:HQ4s@
rkn'1M&u
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© qqSFy>`P
,tak{["
ÃâÒßѧרҵ£º I}u&iV`
V z-]H]MW,
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ }s:~E2?In
IC
+!XZqS
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ bVOJp% *s
c{[ lT2yxU
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ 6rMNp"!
}A&I@2d
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) =)nJ'}x
.q|k459oi
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) :H>0
/^Mg0
2*a5pFkb
1. ADCC(antibody dependent cell-mediated cytotoxicity) nhRpb9f`1@
cFr`9A\-n
2. »·æß¾úËØ(cyclosporin) pyp0SGCM:
k(M(]y_
3. KIR(killer cell inhibitory receptor) {!^0j{T
7
yUX]95y8
4. HLDA(human leucocyte differentiation antigen) 5A+r^xN
Dq+S'x~>
5. Interleukin 18(IL-18) RaOLy \
C4)m4r%
6. ÕûºÏËØ(integrin) !vq|*8
.yB{+
7. Fas/FasL
GK1oS
}#6~/
W
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) ATjE8!gO!
R# ZO<g%'
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) X'j9l4Ph7
ANTWWs}
10. Th1/Th2 eVj7%9
k|^`0~E
11. »ùÒòÒßÃç(DNAÒßÃç) O bc>f|l]
]I\9S{?
12. chemokines and chemokine receptor ]q/USVj{
&]pY~zVc
13. ÃâÒßÄÍÊÜ c$x>6&&L
>4J(\'}m|
14. ¹²´Ì¼¤·Ö×Ó ~SS3gL v
SGu`vN]
15. ËÀÍö½á¹¹Óò(death domain) lN x7$z`
<`WcI`IAb
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) e xkPu-[W
PJ\k
|
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? 7&u$^c S(
Nh\o39=
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠJ?Oeuk~[D
D 9UM8Hxi
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î ,&L}
^ Up
$W%-Mm
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ wo;OkJKF
d4p6.3
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå _fSBb<
!(gSXe)*
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ e^;%w#tEqI
?!O4ia3nFk
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) HiBI0)N}
Vcnc=ct
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ RhC|x,E
8H|ac[hXK2
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ nLCaik_,m
Ks<+@.DLTu
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£